Month: March 2018

Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Novo Holdings optimistic about investments in life sciences Novo Holdings is planning to increase its investment in early & late stage...

Read More

Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Merck and Eisai has entered into an Oncology Pact worth Up to USD 5.76 Billion Two major pharmaceutical companies (Merck & Eisai) has...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Arbor Biotechnologies shining with new CRISPR enzyme Arbor Biotechnologies is shining with its new CRISPR enzyme and has successfully...

Read More

Hyperuricemia – Uric acid disorder, gateway to other diseases

Articles, Business Consultant, Pharma Consultant

Hyperuricemia is a pathological condition occurring due to excess of uric acid in blood (serum uric acid level > 7.0 mg/dL in adult men...

Read More

Cholesterol drug Praluent successful in reducing heart risk in new study

Business Consultant, Snippets

Sanofi and Regeneron Pharmaceuticals got effective results in reducing the risk of major adverse heart events in a clinical study of nearly...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Anthera’s Sollpura flops after phase 3   Anthera cut free it’s flopped late-arrange Lilly castoff Sollpura (liprotamase), and now...

Read More
Close